Narrative intelligence for prifemilast: 1 tracked articles, claims, and spin patterns across AI and technology coverage.
Narrative intelligence for prifemilast across AI and technology coverage.
cAMPfield Strengthens Leadership Team with Key Executive Appointments, Including Graham Heap, MD, PhD as President, R&D, to Advance Prifemilast into Global Phase 2 Development for Inflammatory Bowel Disease
cAMPfield is advancing prifemilast into global Phase 2 development for inflammatory bowel disease.